The Profile of Use of Rituximab in Tertiary Care Hospitals of Central India

BACKGROUND: Rituximab, one of the most commonly used biologics, was once approved by the United States Food and Drug Association (US FDA) for the management of different systemic autoimmune disorders, and it is now used extensively in managing off-label indications. There is a scarcity of data regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Alok, Sahoo, Ajaya K., Biswal, Debadulal, Sheth, Pranav G., Dhaneria, Suryaprakash, Gupta, Dhyuti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084999/
https://www.ncbi.nlm.nih.gov/pubmed/37051423
http://dx.doi.org/10.4103/jpbs.jpbs_520_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084999/
https://www.ncbi.nlm.nih.gov/pubmed/37051423
http://dx.doi.org/10.4103/jpbs.jpbs_520_22

Ejemplares similares